Furaginum APTEO MED 50mg Composition:

The active substance of the drug: furazidine. One tablet contains 50 mg of furazidine. Excipients: maize starch, sucrose, colloidal silica, anhydrous stearic acid.

Action:
Furazidine is a derivative of nitrofuran, it was used in the Furaginum Apteo Med 50mg. It inhibits the growth of bacteria that are responsible for causing urinary tract infections.

Application:
Furaginum Apteo Med 50mg, indicated for use in lower urinary tract infections.

Additional information:
Keep the product out of reach of children at room temperature. It is recommended to avoid drinking alcohol while taking the drug. The drug contains sucrose, which should be taken into account in people with intolerance to some sugars. It is recommended to consult a physician then.

Contraindications:
Do not use in case of hypersensitivity to any component of the drug or to other derivatives of nitrofuran. Do not use in the first trimester of pregnancy, as well as during pregnancy (from week 38) and during delivery. Do not use in children and adolescents. Do not use in the case of renal failure (when creatinine clearance below 60 ml / min or elevated serum creatinine was found in laboratory tests). Do not use when diagnosed with polyneuropathy, eg in the course of diabetes. Do not use in the case of glucose-6-phosphate dehydrogenase deficiency.

Side effects:
Some people may experience side effects while taking the medicine. Common side effects: nausea, excessive gas donation, headache. Uncommon side effects: cyanosis, megablastic anemia or haemolytic anemia; dizziness, drowsiness, blurred vision, peripheral nerve damage; hypersensitivity reactions related to the respiratory system: acute reactions (manifested by fever, chills, cough, chest pain, shortness of breath, exudate to the chest cavity, changes in the radiological image of the lungs and increased number of particular types of white blood cells, most often quickly or very quickly they disappear after discontinuation of the drug); chronic reactions (including pulmonary fibrosis and disseminated interstitial pneumonitis; severity and their reversibility after discontinuation of treatment depends on the time of continuation of treatment after the first adverse effects; after identifying an adverse reaction, immediate discontinuation of the drug is necessary; impaired lung function can be reversible); constipation, diarrhea, dyspeptic symptoms (eg feeling of postprandial fullness, bloating), abdominal pain, vomiting, salivary gland inflammation, pancreatitis, pseudomembranous enteritis; alopecia, exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome; fever, chills, malaise, infection with furazid-resistant microorganisms; pruritus, urticaria, anaphylactic reactions, angioneurotic edema, rash; symptoms of drug-induced hepatitis, cholestatic jaundice, hepatic parenchyma necrosis.

Dosage Furaginum APTEO MED 50mg :

Take as directed by your doctor or the directions on the leaflet. In adults, it is recommended to take two tablets (100mg) 4 times a day on the first day of treatment. In the following days, reduce the daily dose, use two tablets (100mg) three times a day. The drug is taken with a meal that contains protein, because it increases the absorption of the drug. If after 7-8 days of using the preparation the symptoms do not disappear or worsen, you should visit a doctor.